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Abstract 
 The present review study was conducted to review the current 
understanding of molecular aspects of Urtica species. We refer to the most 
recent published articles addressing the therapeutic potential of this plant. A 
wide spectrum of diseases has been associated with Urtica species including   
cancer, arthritis, autoimmune diseases, diabetes, and fatigue. Some 
molecular mechanisms and chemical properties have been discussed. Taken 
together, studies have confirmed the beneficial effects of Urtica all over the 
world and understanding of the molecular mechanisms underlying the 
beneficial effects opens new horizon to understand new therapeutic options. 
The extracts of Urtica should be prepared based on separating effective 
ingredients for optimal therapeutic benefits. 
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Introduction 
     From a historical point of view, medicinal plants have been used by 
human as a traditional way of providing relief to several diseases. No doubt 
that many plant-derived compounds exhibit significant analgesic properties. 
Despite the large progress that has occurred in the development of therapy, 
there is still a need of effective and potent analgesic drugs. In this regard, it 
has been widely shown that many plant-derived substances play a relevant 
role in the process of development of new strategies to treat complaints 
related with pain (Calixto et al., 2000). 
This review study was conducted in the light of the fact that there is a 
necessity to have a monitoring of the adverse effects of herbal medicines and 
to establish a correlation between marker compounds and plants to guarantee 
the efficiency and quality of herbal medicines. One of herbal medicines that 
have received great attention is the Urtica which has many species including 
Urtica dioica L (Ozen and Korkmaz, 2003).  
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Several studies have investigated the therapeutic potential of Urtica 
dioica L. (Urticaceae), or stinging nettle. Hypotensive properties of leaves of 
Urtica dioica L have been demonstrated (Garnier et al. 1961; Ziyyat et al. 
1997). Other studies pointed to anti-inflammatory effects (Reihemann et al. 
1999), prostatic hyperplasia treatment (Kreski et al. 1993; Lichius and Muth, 
1997), diuretic (Tahri et al. 2000) and immunomodulatory activity (Delcourt 
et al. 1996; Musette et al. 1996; Basaran et al. 1997; Rovira et al. 1999), to 
alleviate rheumatic pain (Chrubasik and Eisenberg, 1999), and to serve as an 
adjuvant therapeutic agent in rheumatoid arthritis (Randal et al. 1999).  
Many studies have suggested various mechanisms to explain the 
beneficial effects of Urtica dioica. These mechanisms include 
glucopyranosides (Neugebauer et al. 1995), glycoprotein (Andersen and 
Wolf, 1978), protein (Styprekowska and Bieganska, 1980), flavonol 
glycosides (Chaurasia and Witchtl, 1987; Basaran et al. 2001), carotinoids 
(Kudritskaya et al., 1986). Other studies attributed beneficial effects of  
Urtica dioica  to biologically-active compounds, such as amino acids, 
caffeoyl malic acid and quinic acid (Obertreis et al. 1996). It has also been 
shown that essential oils, formic and acetic acid, histamine, tannins, 
mucilage, vitamins (A, B1, B2, C, K1, folic and pantothesic acids) to be 
identified as contributing to the observed medicinal effects of the plant (Tita 
et al. 1993). Other studies pointed to the use of Urtica dioica for cancer 
treatment positive findings (Baytop, 1984; Samur et al. 2001).  
Urtica pilulifera, is a popular plant found in Palestinian and in Sinai  
(Ali-Shtayeh etal., 2000). It belongs to family Urticaceae and it is 
characterized morphologically by the stinging hairs carried by its leaves and 
flowers which cause irritation to the skin (Fu etal., 2006). A tea made from 
the leaves of Urtica pilulifera has traditionally used as a stimulating tonic, 
blood purifier and hemostatic and for enhancement of hemoglobin 
concentration (Chrubasik etal.,2007). 
      Dina et al (2013) conducted a study to evaluate the potential effects 
of ethylacetate (EA), chloroform (CHLOR) and hexane (HEXA) extracts of 
Urtica pilulifera as oral anti-diabetic agents as well as to evaluate their 
possible anti- oxidant and anti-inflammatory effects in type 2 diabetic rat 
model. The researchers induced the model of Type2 diabetes through a high 
fat diet and low dose streptozotocin (STZ). Diabetic adult male albino rats 
were allocated into groups and treated according to the following schedule; 
Pioglitazone HCL (PIO), EA, CHLOR and HEXA extracts of Urtica 
pilulifera at two doses of 250 and 500mg/kg were used. Control groups were 
included as normal and diabetic control. Blood glucose, insulin resistance, 
antioxidant enzymes, 8-hydroxy-2-deoxyguanosine (8-OHdG) as well as C-
reactive protein and tumor necrosis factor-a levels were evaluated. Study 
findings indicated to significant hypoglycemia associated with antioxidant 
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and anti-inflammatory effects in diabetic rats in EA and CHLOR extracts of 
Urtica pilulifera. It is believed that these activities are responsible, at least 
partly, for improvements that have been seen in hyperglycemia and insulin 
resistance of diabetic rats. Taken together, the previous findings encourage 
the traditional use of Urtica pilulifera extract as an antioxidant and anti-
inflammatory agent as an additional therapy of diabetes.  
In a study by Zhang et al (2013), it was found that the crude 
polysaccharides (UA) which were obtained from Urtica angustifolia. The 
researchers investigated the anti-fatigue activity of the polysaccharides in 
mice and the results showed U. angustifolia polysaccharides had the ability 
to increase the swimming time, and the average swimming time of the low 
doses (LD), middle doses (MD) and high doses (HD) group were increased 
by 85.4, 114.6 and 151.2%, respectively. Furthermore, it was demonstrated 
that the blood urea nitrogen content of the LD, MD and HD group to be 
reduced by12.8, 13.6 and 19.8% compared with that of control group, 
respectively. Moreover, the hepatic glycogen of every treated group was 
higher than that of control group, increasing rates were 87.0, 469.6, and 
747.8%, respectively. 
Gorzalczany et al (2011) conducted a study to investigate the in vivo 
antinociceptive effect of Urtica circularis ethanolic extract and its isolated 
compounds. Antinociceptive activity was evaluated through writhing, 
formalin and hot plate tests in mice. The phytochemical analysis was carried 
out. The study findings showed that the extract had induced significant 
inhibition on nociception induced by acetic acid (ED50:72.2 mg/kg, i.p.) and 
formalin (ED50: 15.8 mg/kg, i.p.) administered intraperitoneally and also 
orally. It has also been found that atropine diminished the activity of the 
extract in the acetic acid test. In this model, it has been indicated that at dose 
of 10 mg/kg i.p., vitexin was the most active of the isolated compounds 
(inhibition of 91%), and chlorogenic acid, caffeic acid and vicenin-2 (6,8-di-
C-glucosyl apigenin) produced an inhibition of 72%, 41% and 41%, 
respectively, whereas apigenin did not show any activity. Taken together, the 
previous findings indicated that Urtica circularis extract produced 
antinociception possibly related to the presence of vitexin, chlorogenic, 
caffeic acid and vicenin-2. Furthermore, the activation of cholinergic 
systems seems to be involved in the mechanism of antinociception of the 
extract. 
Ghaima et al (2013) investigated the antibacterial and antioxidant 
activities of ethyl acetate extract of nettle (Urtica dioica). The researchers 
also investigated phytochemical screening and determination of total 
phenolic content. The results showed that that ethyl acetate extract of nettle 
had good effects on all bacterial isolates (Aeromonas hydrophila, Salmonella 
typhi, Staphylococcus aureus, Bacillus cereus, Escherichia coli) with highest 
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inhibition zone (24 mm) towards B. cereus, A hydrophila was more resistant 
than other bacteria. Also it was found that nettle gave large inhibition zone to 
S. typhi (22mm). Ethyl acetate of nettle had a high content of phenolic 
compounds (48.3mg GAE/gdw). The phytochemical qualitative screening 
exhibited flavonoid, glycosides, phenols, tannins and terpenoids were present 
in nettle alkaloid. Steroids were not present. Evaluation of antioxidant 
activities of ethyl acetate extract of nettle by ferric thiocyanate method 
(FTC) exhibited that nettle caused 76% lipid peroxidation in inhibition of 
linoleic acid emulsion.  
Yohichi Kumaki et al (2011) conducted a study to investigate the 
effects of Urtica dioica agglutinin (UDA). It has N-acetylglucosamine 
specificity that inhibits viruses from Nidovirales in vitro. The efficacy of 
UDA was examined on the replication of different SARS-CoV strains in 
Vero 76 cells. UDA has been shown to prevent virus replication in a dose-
dependent manner and reduced virus yields of the Urbani strain by 90% at 
1.1±0.4_g/ml in Vero 76 cells. UDA was also tested for efficacy in a lethal 
SARS-CoV-infected BALB/c mouse model. The researchers infected 
BALB/c mice with two LD50 (575 PFU) of virus for 4 h before the mice 
were treated intraperitoneally with UDA at 20, 10, 5 or 0 mg/kg/day for 4 
days. The results were amazing since treatment with UDA at 5 mg/kg was 
shown to significantly protect the mice against a lethal infection with mouse-
adapted SARS-CoV (p < 0.001), but did not significantly reduce virus lung 
titers. All virus-infected mice receiving UDA treatments were also 
significantly protected against weight loss (p < 0.001).UDA also effectively 
reduced lung pathology scores. Furthermore, at day 6 after virus exposure, 
all groups of mice receiving UDA had much lower lung weights than did the 
placebo-treated mice. Taken together, the previous findings pointed to UDA 
treatment of SARS infection in mice lead to a substantial therapeutic effect 
that protects mice against death and weight loss. The results of this study 
suggested that UDA might bind to N-acetylglucosamine-like residues present 
on the glycosylated envelope glycoproteins, thereby preventing virus 
attachment to cells. 
Various studies showed that stinging UDA is a small (8.7 kDa) plant 
monomeric lectin with N-acetylglucosamine specificity (Beintema and 
Peumans, 1992; Van Dammeet al., 1988) has been indicated to inhibit 
Nidovirales in vitro with some selectivity (van der Meer et al., 2007). In 
another study, Keyaerts et al. (2007) showed that UDA was shown to be a 
potent and selective inhibitor of SARS-CoV (Frankfurt 1 strain) with an 
EC50 = 1.3±0.1µM and an IC50 of >100µM, resulting in an SI > 76.9. In 
addition, another lectin, the mannose specific lectin Hippeastrum hybrid 
agglutinin (HHA), likely inhibited SARS-CoV attachment to the cells or 
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acted to inhibit the virus at the end of the infectious virus cycle (Keyaerts et 
al., 2007). 
In another study, Ming Xiang (2009) conducted a study to investigate 
the immunosuppressive effects of HPLC qualitied ethyl acetate extract 
(EAE) from Urtica dentate Hand on skin allograft rejection in a murine 
model. The researchers established their model through placing skin allograft 
of C57BL/6 mice in the wound bed which was on the back of Balb/c mice. 
FACS was used to study the effects of EAE on dendritic cells (DCs) 
maturation and CD4+CD25+T regulatory cells (Tregs) differentiation. 
Spleen lymphocyte proliferation was used in addition to T-bet gene 
expression in DCs. Concentration of Th1/Th2 cytokines was monitored as 
markers of Th1/Th2 responses by ELISA. Study findings showed that there 
was a significant prolongation of skin allografts survival in a dose-dependent 
manner in the animals treated with EAE. It was also found that using FACS, 
treatment with EAE (200mgkg−1) resulted in an immature statement of DCs 
and stimulated the differentiation of CD4+CD25+Tregs. Additionally, the 
expression of T-bet gene and the proliferation of spleen lymphocytes were 
efficiently abated in EAE treated mice. In comparison of the model control, 
EAE-treated recipients showed a significant downregulation (P < 0.01) of 
Th1 cytokines (IL-2, IFN-ỵ) and an obviously increase (P < 0.01) of Th2 
cytokine (IL-10) in the serum, which presented in a dose-related way. Taken 
together, the anti-allograft rejection effect of EAE by enhancing 
CD4+CD25+Tregs differentiation and sustaining DCs immaturation makes 
EAE to be a possible choice for treating autoimmune diseases in a way of 
inducing a stable immunological tolerance state. 
It has been reported that Urtica dentata Hand (UDH) is the root of 
Laportea bulbifera (Sieb.et.Zucc.) Wedd, which belongs to the family 
Urticaceae. UDH has been traditionally implicated as an anti-inflammatory 
drug, discutient, immuno-regulatory agent or as a remedy for oedema, 
arthrositis and some other autoimmune diseases. It is believed that UDH 
possess the ability to dispelling wind, eliminating dampness, promoting 
urination and obviating edemas (Wan et al., 2002). 
Other studies have shown that the ethyl acetate extract (EAE) of 
UDH possessed powerful immunosuppressive abilities in vitro (Wang et al., 
2007) and showed preventive action on collagen induced arthritis in mice 
(Xiang et al., 2006).  
Ozen and Korkmaz conducted a study some metabolic effects 
associated with administration of extract of Urtica dioica L. The authors 
reported the experimental trials of two doses (50 and 100 mg/kg body wt 
given orally for 14 days). Study findings indicated that there were significant 
increased activities compared with control in liver for cytochrome b5 (cyt 
b5), NADH-cytochrome b5 reductase (cyt b5 R), glutathione S-transferase 
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(GST), DT-diaphorase (DTD), glutathione peroxidase (GPx), glutathione 
reductase (GR), superoxide dismutase (SOD) and catalase (CAT). Findings 
also indicated that there were significantly decreased activities of 
cytochrome P450 (cyt P450), lactate dehydrogenase (LDH), NADPH-
cytochrome P450 reductase   ( cyt P450 R), total sulfhydryl groups (T-SH), 
nonprotein sulfhydryl groups (NP-SH) and protein bound sulfhydryl groups 
(PB-SH).  
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